The Joint 23rd Medicines for Europe – 20th IGBA Annual Conference will unite over 300 experts from the generic and biosimilar sectors to discuss market trends, innovative comm
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
